Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2012-002819-26-IT
EUCTR2012-002819-26-IT
Active, not recruiting
Not Applicable

FMISO F18 PET/CT as marker of hypoxia in patients undergoing radio- and chemotherapy - FMISO PET/CT in tumours

CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA0 sitesOctober 25, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA
Status
Active, not recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 25, 2012
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA

Eligibility Criteria

Inclusion Criteria

  • •Patients for whom is mandatory to assess the hypoxia and to monitor therapy efficay early
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range: 0
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 70
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 30

Exclusion Criteria

  • •Age \<18 yrs. o \>90 yrs

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
Clinical Evaluation of the New Hypoxia Imaging Agent HX4Head and Neck CancerLung CancerLiver Cancer
NCT01213030Siemens Molecular Imaging12
Completed
Not Applicable
Tumor hypoxia measured with F-MISO-PET in the course of irradiation of head and neck cancer: adoption of the method into clinical routine and evaluation of the dataC10C13Malignant neoplasm of oropharynxMalignant neoplasm of hypopharynx
DRKS00006007niversitätsklinikum DresdenKlinik für Strahlentherapie und Radioonkologie59
Completed
Phase 1
Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerNon-small Cell Lung Cancer
NCT01017133Abramson Cancer Center at Penn Medicine56
Recruiting
Not Applicable
FAZA PETMRI Gastro-Oesophageal StudyMetastasized Gastro-Oesophageal Cancer
NCT04560036University Health Network, Toronto40
Completed
Not Applicable
Hypoxia imaging with 18F-Misonidazole PET in brain metastasismetastatic brain tumor
JPRN-UMIN000014572Departments of Radiation Oncology, Hokkaido University Hospital25